Skip to content

Effect of intraoperative high-flow nasal oxygen therapy with a non-intubated anesthesia approach on early postoperative pulmonary function improvement in patients undergoing thoracoscopic lung surgery

Effect of intraoperative high-flow nasal oxygen therapy with a non-intubated anesthesia approach on early postoperative pulmonary function improvement in patients undergoing thoracoscopic lung surgery

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123947
Enrollment
Unknown
Registered
2026-05-04
Start date
2026-05-04
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early postoperative pulmonary dysfunction

Interventions

Double-lumen tube group (Control group):Conventional double-lumen tube bronchial intubation followed by mechanical ventilation via anesthesia machine. During bilateral lung ventilation: tidal volume 6
during single-lung ventilation: tidal volume 4–6 mL/kg, respiratory rate 15–18 breaths/min, inspired oxygen concentration 100%. Arterial blood gas analysis performed 15 minutes after extubation while
LMA group (Trial Group 1):After anesthesia induction, a laryngeal mask airway (LMA) was inserted and spontaneous breathing was maintained. Inspired oxygen concentration 100%, oxygen flow 2.0–5.0 L/min
Nasal high-flow oxygen group (Trial Group 2):After anesthesia induction, high-flow nasal oxygen was administered. Arterial blood gas analysis performed 15 minutes after emergence while breathing room

Sponsors

Peking University People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective thoracoscopic lung wedge resection; 2. Aged 18 to 64 years; 3. Body mass index (BMI) = 26 kg/m^2; 4. American Society of Anesthesiologists (ASA) classification ?–?; 5. Abstained from smoking for more than 2 weeks; 6. Signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with a clear diagnosis of severe airway hyperresponsiveness before surgery; 2. Patients with preoperative pulmonary infection; 3. Patients with severe chest deformity resulting from recent acute chest trauma or prior remote trauma; 4. Patients allergic to local anesthetics; 5. Patients with severe dysfunction of vital organs (e.g., heart, lungs, liver, kidneys) or with hematological diseases; 6. Patients with a prior history of neurological or psychiatric disorders; 7. Patients who withdraw during the study or are unable to cooperate fully; 8. Any patient judged by the investigator to be unsuitable for participation in this study; 9. Patients who have participated in other clinical trials related to pulmonary function within the past 4 weeks.

Design outcomes

Primary

MeasureTime frame
The rate of change in the oxygenation index (?OI);

Secondary

MeasureTime frame
Postoperative pain scores;Anesthesia duration;Surgical duration;Awakening time;Blood loss;Total fluid infusion volume;Anesthetic drug consumption;Vasoactive drug dose;Postoperative throat discomfort;Patient satisfaction;Surgeon satisfaction;Postoperative length of hospital stay;Medical costs;Incidence of postoperative pulmonary complications;

Countries

China

Contacts

Public ContactLiang Hansheng

Peking University People’s Hospital

doc_lianghansh@sina.com+86 137 1792 9362

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 16, 2026